Profitability Ratios
| Ratio |
Value |
| GP Margin |
62.6% |
| EBIT Margin |
7.4% |
| EBITDA Margin |
17.6% |
| Operating Margin |
6.8% |
| Pretax Margin |
2.5% |
| Cont. Ops Margin |
-0.8% |
| Net Margin |
-0.8% |
| Bottom Line Margin |
-0.8% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
0.63 |
| Quick Ratio |
0.47 |
| Solvency Ratio |
0.082 |
| Cash Ratio |
0.17 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
3.29 |
| Forward PEG |
3.29 |
| Price/Book |
4.03 |
| Price/Sales |
2.67 |
| Price/FCF |
15.23 |
| Price/Op Cash Flow |
13.76 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.4188 |
| Debt/Equity |
1.1354 |
| Debt/Capital |
0.5317 |
| Long-Term Debt/Capital |
0.3248 |
| Financial Leverage |
2.71 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
128.11 |
| Operating Cash Flow Ratio |
0.285 |
| Operating Cash Flow/Sales |
19.4% |
| Free Cash Flow/Operating Cash Flow |
90.4% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
0.30 |
| Interest Coverage |
1.3775 |
| Short-Term Operating Cash Flow Coverage |
0.46 |
| Operating Cash Flow Coverage |
0.26 |
| Capital Expenditure Coverage |
10.40 |
| Dividend + Capital Expenditure Coverage |
5.88 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
-175.6839% |
| Dividend Yield |
0.5383% |
| Dividend Yield % |
0.5383% |
| Dividend Per Share |
0.6388 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
44.39 |
| EPS |
-0.364 |
| Debt/Share |
35.6108 |
| Cash/Share |
5.03 |
| Book Value/Share |
29.44 |
| Tangible BV/Share |
-21.88 |
| Equity/Share |
29.44 |
| Operating Cash Flow/Share |
8.622 |
| Capital Expenditure/Share |
0.829 |
| FCF/Share |
7.793 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
-0.331 |
| Earnings Before Tax/EBIT |
0.365 |
| Price/Fair Value |
4.03 |
| Debt/Market Cap |
0.2762 |
| Effective Tax Rate |
133.1% |
| Enterprise Value Multiple |
18.85 |
MLAB - Mesa Laboratories, Inc.